Advertisement

Topics

Tetraphase Pharmaceuticals Inc. Company Profile

01:44 EDT 27th July 2016 | BioPortfolio

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs such as the treatment of serious drug-resistant and gram-negative infections. The company has developed an emerging pipeline of potent novel antibiotics that provide a portfolio of intravenous and oral drug candidates with the potential to treat a wide range of infections, including broad-spectrum and selective-spectrum infections. To learn more about Tetraphase, please visit www.tphase.com.


News Articles [1096 Associated News Articles listed on BioPortfolio]

Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Tetraphase Pharmaceuticals, Inc. to Contact the Firm Before Lead Plaintiff Deadline

NEW YORK, NY--(Marketwired - February 08, 2016) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tetraphase Pharmaceuticals, Inc. ("Tetraphase" or the "Company"...

Tetraphase Pharmaceuticals offers update on eravacycline regulatory and development status

Tetraphase Pharmaceuticals has received guidance from the U.S. Food and Drug Administration (FDA) regarding the regulatory path of the Company's lead candidate, eravacycline, an antibiotic with potent...

Larry Tsai of Tetraphase Pharmaceuticals: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Dr. Larry W. Tsai has been Vice President of Clinical Development of Tetraphase Pharmaceuticals since 2015. In this role he establishes clinical development plans and ... The post Larry Tsai of Tetrap...

Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals

NewsLundin Law PC announces securities class action lawsuit against Tetraphase Pharmaceuticals, Inc.Contributed Author: 

Shares Of Tetraphase Tumble 26% Lower After FDA Guidance

On Thursday, shares of Tetraphase Pharmaceuticals (NASDAQ:TTPH) which was under pressure in the day’s session, tumbling 7.5%), has fallen 26% in after-hours trading after the company provided a...

Tetraphase Pharmaceuticals to Present at Needham Conference 2016

WATERTOWN, Mass., April 06, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threaten...

Tetraphase Pharmaceuticals Added to the Russell Microcap® Index

WATERTOWN, Mass., June 28, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threateni...

Tetraphase Pharmaceuticals to Present at Roth Conference 2016

WATERTOWN, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threaten...

Drugs and Medications [0 Results]

None

PubMed Articles [144 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Removal of pharmaceuticals from secondary effluents by an electro-peroxone process.

This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involv...

Ranking Prescribed Pharmaceuticals in Terms of Environmental Risk: Inclusion of Hospital Data and the Importance of Regular Review.

A newly available dataset on pharmaceuticals used in Scottish hospitals enabled an Environmental Risk Assessment that includes hospital consumption of pharmaceuticals, as previous UK rankings have bee...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

The purpose of this study is to compare the safety and efficacy profiles of Watson Laboratories, Inc.'s Pimecrolimus Cream, 1% to those of Valeant Pharmaceuticals North America LLC's Elide...

TOL-463 Phase 2 Study

This is a Phase II randomized single blind (investigator-blinded) safety and efficacy study in approximately 90 adult females 18-50 years of age (to achieve 80 evaluable participants) at t...

Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)

This phase III clinical study will be conducted in Brazilian research sites. It will be included in the study 314 participants diagnosed with primary knee OA according to the classificatio...

Siltuximab in Schizophrenia

This study is a Phase 1 clinical trial to determine the safety, tolerability, and efficacy of Siltuximab (Sylvant) as an adjunct to antipsychotic medications in stable outpatients with sch...

Companies [3 Associated Companies listed on BioPortfolio]

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-gen...

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the gl...

Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation...

More Information about "Tetraphase Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Tetraphase Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Tetraphase Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Tetraphase Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tetraphase Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Tetraphase Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record